rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Bob G. Gower

Director

Company insider

Files Form 4 as: Director and 10% owner, Ensysce Biosciences; Director, Miller Energy Resources; Director, Kirby.

Every Form 4 they filed

In numbers

Trades disclosed
130
Buys
10
Sells
9
Bought
$1.9M
Sold
$8.0M
Companies
3
Companies where not an officer
3
First trade
21 Dec 2005
Last trade
7 Aug 2026
Last filed
18 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ENSC Ensysce BiosciencesDirector, 10% owner · Biotechnology · last 7 Aug 20266 buys · 0 sells
Miller Energy ResourcesDirector · last 29 Mar 20164 buys · 0 sells
KEX KirbyDirector · Marine Shipping · last 9 Oct 20140 buys · 9 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
7 Aug 2026filed 18 Aug 2026ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$198K400,000 at $0.495filing
7 Aug 2026filed 18 Aug 2026ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$200K400,000 at $0.50filing
23 Apr 2026filed 18 Aug 2026ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$246K508,614 at $0.484filing
23 Apr 2026filed 18 Aug 2026ENSC Ensysce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code C—254,307filing
23 Apr 2026filed 18 Aug 2026ENSC Ensysce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code C—254,307filing
23 Apr 2026filed 18 Aug 2026ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$244K508,614 at $0.48filing
2 Mar 2023filed 6 Mar 2023ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$44K90,287 at $0.49filing
1 Mar 2023filed 2 Mar 2023ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$130K270,000 at $0.48filing
28 Feb 2023filed 2 Mar 2023ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$54K109,300 at $0.49filing
9 Dec 2022filed 1 Feb 2023ENSC Ensysce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—714,286filing
9 Dec 2022filed 1 Feb 2023ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Bought$500K357,143 at $1.40filing
23 Jun 2022filed 27 Jun 2022ENSC Ensysce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—15,000filing
4 Feb 2022filed 4 Feb 2022ENSC Ensysce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—20,000filing
30 Jun 2021filed 2 Jul 2021ENSC Ensysce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—6,585filing
30 Jun 2021filed 2 Jul 2021ENSC Ensysce BiosciencesBiotechnologySEC FORM 4 Code A—7,919,026filing
29 Mar 2016filed 31 Mar 2016Miller Energy ResourcesSEC FORM 4 Code J—196,696 at $0.00filing
29 Mar 2016filed 31 Mar 2016Miller Energy Resourcesoption or derivativeSEC FORM 4 Code J—20,000 at $0.00filing
29 Mar 2016filed 31 Mar 2016Miller Energy Resourcesoption or derivativeSEC FORM 4 Code J—20,000 at $0.00filing
29 Mar 2016filed 31 Mar 2016Miller Energy Resourcesoption or derivativeSEC FORM 4 Code J—20,000 at $0.00filing
29 Mar 2016filed 31 Mar 2016Miller Energy Resourcesoption or derivativeSEC FORM 4 Code J—20,000 at $0.00filing

News

Ensysce Biosciences Expands Global Investor and Strategic Outreach ...ENSC · pr-inside.com · 21 Oct 2026

0 headlines in the last 90 days name Bob G. Gower; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Industrials9
Health Care6
Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.